Research institute
Appears in 1 story · Last updated Sep 7, 2026
As of September 2026: Co-developer of Mprosevir
Westlake University announced September 2 that China's drug regulator conditionally approved Mprosevir, a COVID-19 treatment. It is the country's first 'Class 1' innovative drug developed with AI assistance—the highest tier of China's drug registration system, for drugs never marketed before.
Updated Sep 7
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
